GET THE APP

Empowering Patients: Advocacy and Support for those Affected by Cardiomyopathy
..

Cardiovascular Diseases & Diagnosis

ISSN: 2329-9517

Open Access

Opinion - (2024) Volume 12, Issue 2

Empowering Patients: Advocacy and Support for those Affected by Cardiomyopathy

Carloni Jaume*
*Correspondence: Carloni Jaume, Department of Nephrocardiology, Zaporizhzhya State Medical and Pharmaceutical University, 69035 Zaporizhzhya, Ukraine, Email:
Department of Nephrocardiology, Zaporizhzhya State Medical and Pharmaceutical University, 69035 Zaporizhzhya, Ukraine

Received: 27-Mar-2024, Manuscript No. jcdd-24-135894; Editor assigned: 29-Mar-2024, Pre QC No. P-135894; Reviewed: 12-Apr-2024, QC No. Q-135894; Revised: 17-Apr-2024, Manuscript No. R-135894; Published: 24-Apr-2024 , DOI: 10.37421/2329-9517.2024.12.603
Citation: Jaume, Carloni. “Empowering Patients: Advocacy and Support for those Affected by Cardiomyopathy.” J Cardiovasc Dis Diagn 12 (2024): 603.
Copyright: © 2024 Jaume C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

Cardiomyopathy, a condition where the heart muscle becomes weakened or enlarged, poses significant challenges for those affected. Whether it's hypertrophic cardiomyopathy, dilated cardiomyopathy, or another form, the impact on patients' lives can be profound. However, amidst the complexities and uncertainties, there's a beacon of hope: empowerment through advocacy and support. This article delves into the importance of empowerment in navigating the journey of cardiomyopathy and how advocacy and support can make a substantial difference [1].

Before delving into empowerment strategies, it's crucial to grasp the nature of cardiomyopathy. This condition can manifest in various ways, such as reduced heart function, irregular heartbeats and even sudden cardiac arrest. Symptoms may include shortness of breath, fatigue, swelling of the lower extremities and chest pain. The diagnosis can be overwhelming, often accompanied by fear and uncertainty about the future. One of the most potent tools in combating cardiomyopathy is knowledge. Empowering patients with information about their condition, treatment options and lifestyle modifications can foster a sense of control and agency. Healthcare providers play a pivotal role in this process by educating patients and involving them in decision-making regarding their care. Additionally, reliable online resources, patient support groups and educational materials can supplement healthcare professionals' guidance, enabling patients to become informed advocates for their health [2].

Empowerment goes hand in hand with advocacy. Patients and their loved ones can advocate for better care by actively participating in their healthcare journey. This involves asking questions, seeking second opinions and voicing concerns about treatment plans. Advocacy also extends to raising awareness about cardiomyopathy within communities and advocating for increased research funding and access to specialized care. By becoming vocal advocates, patients not only empower themselves but also contribute to improving the quality of care for others facing similar challenges [3].

Description

Navigating cardiomyopathy can be emotionally taxing, underscoring the importance of robust support networks. Family, friends and support groups can offer invaluable emotional support, understanding and encouragement. Connecting with others who share similar experiences can alleviate feelings of isolation and provide practical insights into coping strategies. Furthermore, support networks serve as platforms for sharing resources, navigating healthcare systems and advocating collectively for improved services and policies. The impact of cardiomyopathy extends beyond the physical realm, often affecting patients' mental and emotional well-being. Psychosocial support, including counseling, therapy and peer support programs, is essential for addressing the emotional toll of living with a chronic condition. By prioritizing mental health and seeking appropriate support, patients can better cope with stress, anxiety and depression, thereby enhancing their overall quality of life [4].

While medical interventions are crucial in managing cardiomyopathy, lifestyle modifications play a complementary role in promoting heart health and overall well-being. Empowering patients to adopt healthy habits such as regular exercise, a balanced diet, stress management techniques and smoking cessation can significantly improve their prognosis and quality of life. By taking an active role in self-care and adhering to prescribed treatments, patients can exert control over their condition and optimize their health outcomes [5].

Conclusion

Empowering patients affected by cardiomyopathy involves equipping them with knowledge, fostering advocacy, cultivating support networks, addressing psychosocial needs and promoting lifestyle management. By embracing empowerment strategies, patients can navigate the challenges of cardiomyopathy with resilience, confidence and a sense of agency. As we continue to advance in medical research and patient-centered care, empowerment remains a cornerstone in improving outcomes and enhancing the overall well-being of individuals living with cardiomyopathy.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Nef, Holger M., Helge Möllmann, Pirmin Hilpert and Christian Troidl, et al. “Activated cell survival cascade protects cardiomyocytes from cell death in tako‐tsubo cardiomyopathy.”Eur J Heart Fail11 (2009): 758-764.

    Google Scholar, Crossref, Indexed at

  2. Liao, Xudong, Eugene Chang, Xinmiao Tang and Ippei Watanabe, et al. “Cardiac macrophages regulate isoproterenol-induced takotsubo-like cardiomyopathy.”JCI insight7 (2022).

    Google Scholar, Crossref, Indexed at

  3. Ghadri, Jelena R., Annahita Sarcon, Johanna Diekmann and Dana Roxana Bataiosu, al. “Happy heart syndrome: Role of positive emotional stress in takotsubo syndrome.”Eur Heart J37 (2016): 2823-2829.

    Google Scholar, Crossref, Indexed at

  4. Medina de Chazal, Horacio, Marco Giuseppe Del Buono, Lori Keyser-Marcus and Liangsuo Ma, et al. “Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review.”J Am Coll Cardiol72 (2018): 1955-1971.

    Google Scholar, Crossref, Indexed at

  5. Prokudina, Ekaterina S., Boris K. Kurbatov, Konstantin V. Zavadovsky and Alexander V. Vrublevsky, et al. “Takotsubo syndrome: Clinical manifestations, etiology and pathogenesis.”Curr Cardiol Rev17 (2021): 188-203.

    Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 427

Cardiovascular Diseases & Diagnosis received 427 citations as per Google Scholar report

Cardiovascular Diseases & Diagnosis peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward